Back to Authors

Azad, Marisa A

Mayo Clinic

Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.

Citations 1

Management of Periprosthetic Joint Infections After Hemiarthroplasty of the Hip
Bureau, Antoine, Azad, Marisa Ann , Abdelbary, Hesham , Azad, Marisa A, Azad, Marisa , Bourget-Murray, Jonathan , Grammatopoulos, George , Garceau, Simon P.

JBJS Reviews | September 26, 2022 | Volume: 10 | Issue: 9 | Pages: No page available

10.2106/jbjs.rvw.22.00020 Get It

» Periprosthetic joint infection (PJI) following hip hemiarthroplasty (HA) is a devastating complication, incurring immense health-care costs associated with its treatment and placing considerable burden on patients and their families. These patients often require multiple surgical procedures, extended hospitalization, and prolonged antimicrobial therapy. » Notable risk factors include older age, higher American Society of Anesthesiologists (ASA) score, inadequate antibiotic prophylaxis, non-antibiotic-loaded cementation of the femoral implant, longer duration of the surgical procedure, and postoperative drainage and hematoma. » Although the most frequent infecting organisms are gram-positive cocci such as Staphylococcus aureus , there is a higher proportion of patients with gram-negative and polymicrobial infections after hip HA compared with patients who underwent total hip arthroplasty. » Several surgical strategies exist. Regardless of the preferred surgical treatment, successful management of these infections requires a comprehensive surgical debridement focused on eradicating the biofilm followed by appropriate antibiotic therapy. » A multidisciplinary approach led by surgeons familiar with PJI treatment and infectious disease specialists is recommended for all cases of PJI after hip HA to increase the likelihood of treatment success.